Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoint inhibitors, according to new research from The University of Texas MD Anderson Cancer Center.
The study, published today in Nature Communications, found that poor infiltration of the tumor by immune cells, low activity from available...
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop...
The University of Texas MD Anderson Cancer Center today was awarded more than $20 million from the Cancer Prevention and Research Institute...
The University of Texas MD Anderson Cancer Center today announced the Houston Dash will join the institution's efforts toward one goal: end cancer. Beginning with the 2020 season, MD Anderson will serve as the official cancer center and jersey partner of the Houston Dash from the National Women's Soccer League (NWSL) and continue to serve in the same role for the two-time Major League Soccer (MLS) champion Houston Dynamo. The...
Loss of an important tumor-suppressing gene allows head and neck cancer to spin off signals to nearby nerves, changing their function and...
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric...
A study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell components known as...
The University of Texas MD Anderson Cancer Center honors World Cancer Day, Feb. 4, as the campaign celebrates 20 years of bringing awareness...